Trytosaveabit OP : Geron Corporation Announces up to $375 Million in Funding With Royalty Pharma and Pharmakon Advisors
Trytosaveabit OP : Geron Corporation Announces up to $375 Million in Funding With Royalty Pharma and Pharmakon Advisors